All In Biotech

Free tool

FAERS Monitor: Alimta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021677 or its brand name (Alimta, Pemetrexed). Reports on generic versions are filed under their own applications.

Reports

16,927

Serious

15,517

92% of reports

Hospitalization

8,359

Death reported

3,495

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • malignant neoplasm progression1,432
  • off label use1,238
  • death939
  • nausea915
  • anaemia873
  • diarrhoea851
  • pancytopenia821
  • neutropenia729
  • fatigue727
  • thrombocytopenia685
  • rash681
  • dyspnoea670
  • pyrexia640
  • vomiting640
  • asthenia580

Reports by year received

View as table
YearReports
2004131
2005406
2006368
2007296
2008279
2009469
2010624
2011658
2012952
2013541
2014585
20151,671
2016556
2017736
2018958
20191,371
20201,268
20211,128
2022873
2023691
2024840
2025866
2026660

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,232 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pancytopeniaSignal82118.517.313,419
malignant neoplasm progressionSignal1,43217.616.722,209
thrombocytopeniaSignal6857.77.13,951
neutropeniaSignal7296.76.23,528
anaemiaSignal8735.75.43,402
pyrexiaSignal6402.32.1476
rash6811.91.8317
asthenia5801.91.8258
off label use1,2381.81.7421
vomiting6401.71.6184
diarrhoea8511.61.5218
dyspnoea6701.51.4103
nausea9151.41.3126
death9391.41.390
fatigue7271.21.117

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.